Average Co-Inventor Count = 3.79
ph-index = 34
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Samumed, LLC (96 from 115 patents)
2. Biosplice Therapeutics, Inc. (9 from 18 patents)
3. Targegen, Inc. (8 from 13 patents)
4. Endeavor Biomedicines, Inc. (4 from 5 patents)
5. The Scripps Research Institute (3 from 1,186 patents)
6. Leland Stanford Junior University (2 from 5,262 patents)
7. Impact Biomedicines, Inc. (1 from 2 patents)
121 patents:
1. 12447148 - Methods of improving lung function
2. 12295954 - Methods of treating fibrosis
3. 12213974 - Methods of treating fibrosis
4. 11839679 - Gamma-diketones for treatment and prevention of aging skin and wrinkles
5. 11780823 - Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors
6. 11697649 - Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof
7. 11684615 - Methods of using indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors
8. 11673885 - γ-diketones as Wnt/β-catenin signaling pathway activators
9. 11667632 - 2-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereof
10. 11628167 - Method of treating fibrosis
11. 11560378 - Treatment of osteoarthritis
12. 11400092 - Methods of treating myeloproliferative disorders
13. 11077046 - Gamma-diketones for treatment and prevention of aging skin and wrinkles
14. 11066388 - Indazole-3-carboxamides and their use as WNT/B-catenin signaling pathway inhibitors
15. 11034682 - Gamma-diketones as wnt/β-catenin signaling pathway activators